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SUMMARY.-A possible basis for the differences in malignancy between three
closely related sublines of the WBP1 ascites tumour of the rat has been studied
by examining the biochemical changes in rat sera during tumour growth
in vivo. Death appeared to be due to hypoglycaemia and the ability to induce
this condition correlated with the differences in malignancy between the sub-
lines; WBP1 (X) and WBP1 (V), the more malignant sublines, inducing hypo-
glycaemia earlier and more rapidly than the least malignant subline WBP1 (A).
Possible mechanismswhereby the tumourproduces these effects are discussed.
SMITH, WILLIAMS, LoWERY AND KEPPIE (1968) and Williams, Lowery and
Smith (1968), described the production of two ascites sublines ofdiffering malig-
nancy derived from a benzopyrene-induced rat tumour (WBPI) and compared
their patterns ofintraperitoneal growth and blood and visceral invasion. WBP1
(A) killed rats in approximately 31 days (I x 101 cells i.p.) and WBPI (V) in
approximately 15days. This difference did not appear to be due to fastergrowth
of the more malignant subline because at 15 days, the estimated amount of A
subline in ratsequalled that ofV andyet the rats with V weredying; and at death
significantly more A than V was present. The difference in malignancy could
have been due either to preferential invasion of some vital organ by the more
malignant subline or to differential interference with metabolism, possibly by the
production ofharmful substances. Theproduction oftoxinsby tumours has been
studied (Sylve'n and Holmberg, 1965; Nakahara, 1968) and that tumour's of dif-
fering malignancy might differ in their toxicities has been suggested (Sylve'n and
Holmberg, 1965).
Biochemical changes observed in serum, urine and the body fluids, associated
with various diseases, often indicate the nature ofthepathologicalchange and the
organ involved. In human medicine, automated analysis (Whitehead, 1968) of
approximately 14 selected substances in serum detects some aspect of many
diseases and additional serum components can be determined subsequently if
necessary. This paper describes attempts to determine the basis of the different
malignancies ofthe WBPI sublinesbyexamining rat sera inthis mannerduringthe
growth ofWBPI (A), WBPI (V) and WBPI (X), the lastbeing an even moremalig-
nant subline derived by intraperitoneal passage of WBPI (V) (see Materials and
Methods). By following the biochemical changes from tumour inoculation until
death it was hoped that the primary changes initiated by the tumour might be
differentiated from secondary deterioration effects in the terminal stages of the
disease.94 KILLINGTON, WILLIAMS, RATCLIFFE, WHITEHEAD AND SMITH
MATERIALS AND METHODS
Rats
250-300 g. males of the inbred black and white hooded strain (Chester Beatty
Research Institute) were used in randomised groups.
Tumoursubline8
WBP1 (A) and WBP1 (V).-These were prepared and stored as described
previously (Smith et al., 1968).
WBPI (X).-This subline was derivedfromWBPI (V)byserialintraperitoneal
passage in isogeneic rats in a manner analogous to the derivation of WBP1 (V)
from WBPI (A) (Smith et al., 1968). Primary stock was frozen at the 49th
ascites passage and working stock at the 50th passage from the original solid
tumour. The cells of the 50th passage were passaged once and then used for
experimentsduringthe 52ndpassage. WheninjectedintraperitoneallyWBPI (X)
(I X 107 cells)produced a mean death time of 11-0 ± 0-5days and was thussigni-
ficantly more malignant than WBPI (V) (15-1 ± 0-2 days).
Insulin
Crystalline insulin (Allen andHanbury and BritishDrugHouses) was dissolved
in 0-85% sodium chloride solution (1-0 unit per ml.).
Glucose
For abdominal infusion, glucose (British Drug Houses A.R. grade) was dis-
solved in water (5-5 g. per litre isotonic solution) and sterilizedby filtration (Milli-
pore (U.K.) Ltd., 0-22
Saline
Sodium chloride (8-5g.) was dissolved in water (I litre) and sterilized by auto-
claving.
Tyrode-gelatin-citrate solution (T.G.C.) see Smith et al. (1968).
Histology
Tissues were fixed in formol saline, embedded in Paraplast (Shandon Ltd.),
sectioned and stained with haematoxylin and eosin.
Insertion ofintraperitoneal cannula
A rat, anaesthetized with an oxygen-fluothane (I.C.I. Pharmaceuticals Ltd.)
mixture, was shaved on the right side, the site sterilized with alcohol and the
abdominal wall exposed through a skin incision (5 mm.). A sterile needle
(31 in. x 159) was inserted through the incision into the peritoneal cavity and
sterilevinyltubing (Becton, Dickinson, U.K., Ltd.)passedthrough the needle bore
until about 10 cm. of tubing was inside the cavity. The needle was carefully withdrawnleaving about 50 cm. oftubing outside the rat. A loop was formed in
the tubing and stitched to the edge of the incision. The latter was then closed
with a Michel clip and the area sprayed with Chloromyeetin (Parke-Davis). The95 HYPOGLYCAEMIA AND MALIGNANCY DIFFERENCES
rat was placed in a restraining cage (9 x 21 x 21 inches) which allowed access to
food and water but prevented the animal biting the external tubing.
Collection of serum and biochemical determinations
Blood, removed from the heart and thorax of rats (4) killed by ether, was
clotted(90 min. at 20' C.) andthe seracollected,centrifuged(2000 r.p.m.; 15 min.).
pooled (seelater) and when necessary stored at 20' C. Biochemical assays were
made within 48 hours of sampling, using an Auto-analyser (Technicon), by the
following methods:glucose (Brown, 1961); creatinine (modifiedfrom Folin andWu,
1919); urea (Marsh, Fingerhaut and Miller, 1965); sodium, by lithium flame
photometry; potassium, by flame photometry; alkaline phosphatase (Marsh,
Fingerhaut and Kirsch, 1959); bilirubin (Gambino and Schreiber, 1964); total
protein (Weichselbaum, 1946); albumin (Bartholomew and Delaney, 1966);
globulin (by difference; total protein-albumin); serum glutamic-oxaloacetic
transaminase (SGOT; Babson, Shapiro, Williams and Phillips, 1962); calcium
(Kessler and Wolfmen, 1964); iron (Young and Hicks, 1965); uric acid (modified
from Lofland and Crouse, 1965); and cholesterol (Huang, Chew, Wefler and
Rafferty, 1961). Glucose, in serum and in tail and heart blood, was also deter-
mined manually by the glucose-oxidase-peroxidase method (Biochemical Test
Combination; Boehringer Mannheim GmbH.).
EXPERIMENTAL AND RESULTS
Biochemical changes in rat sera following intraperitoneal inoculation of WBPI
tumour cells
WBPI (A) and WBPI (V) sublines.-Groups of rats received WBPI (A) cells,
WBPI (V) cells (I x 101 i.p.) or T.G.C. (I ml. i.p.). At intervals during tumour
growth, four rats from each experimental group and four from the control group
were killed and biochemical assays made onthepooled sera from each group (Fig. I
and 2). Pooling of sera was necessary to obtain sufficient for all the assays.
Creatinine levels are not shown as no deviation from control values were observed
in any tumour-bearing animals.
The trends of changes in the serum concentrations of the solution estimated
associated with growth of either subline were similar but the changes occurred
earlier in rats bearing V rather than A subline. For most components (alkaline
phosphatase, cholesterol, sodium,potassium, calcium, iron, albumin,globulin, urea
uric acid and bilirubin) deviations from normal values did not occur or became
apparent only during the terminal stages of tumour growth (Fig. 1). However
the serum glucose and SGOT concentration deviated from the normal 8-10 days
after inoculation of V subline and 12-15 days for the A subline and became
progressively more abnormal until death (Fig. 1 and 2). It seemed possible,
therefore, that low glucose levels might be a primary rather than a secondary
effect of tumour growth and might be the main cause of death.
In the above experiments, rats had been killed at definite time intervals after
inoculation but at indeterminate times before they would have died of tumour.
Theupward trend in theglucose concentration, duringdays 16-17 ofgrowth ofthe
V subline, was biased, since the samples contained rats surviving longer than the
population mean. To answer the question
" were WBPI (V) and WBPI (A)
killing as a direct result ofhypoglyeaemia ", the serum glucose concentration atL)
125 4
1 1 ----I
oi r i Nn -4
to A --'30
96 KILLINGTON, WILLIAMS, RATCLIFFE, WHITEHEAD AND SMITH
1.0 CHOLESTEROI
mg-/looml.
0
0
b a. %- No- --- -------------- 0,00,;;,4, A
;e-\-:1
-------------
2y -\-, A& A
Y\A
0
,& A- --%.
&4
I I I I I
165 101L. I SODIUM
meql.
155
145
135
I I I I
F- 300 CALCIUM
nviioomi.
IRON
)Uqlooml.
I-
- - - - - - - - - - - -25OF
1 150
91 100
ial I I =t%l
I -Ili 5 0 5 10 19 20 25 -30- 6' 1, 1,5
DAYS AFTER TUMOUR INOCULATION
FIG. la.-Changes in serum componentsfollowing inoculation ofWBP1 (A) (0) or WBPI (V) (A) CenS (I X 107) i.p. The dotted lines show the 95% fiducial limits ofthe means ofvalues
measured from the sera of control rats (T.G.C. solution; 1 ml. i.p.), sampled over the same
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FiG. 2.-Changes in serum glucose following the inoculation of WBP1 (A) (0) or WBPI (V)
(A) cells (I X 107) i.p. The dotted lines show the 95% fiducial limits ofthe means ofvalues
measured from the sera of control rats (T.G.C. solution; I ml. i.p.), sampled over the same
period. Values are for pooled sera (4 rats).
death wasrequired. Rats dying ofA or V subline (I x 107 cells i.p.) were there-
fore observed until respiration ceased when they were bled. In the hours before
death, the fur ofthe rats was ruffled andthey were comatose apart from occasional
muscular' spasms. Rectal temperatures decreased from 37' C. to 26-32' C. at
death (ambient temperature 23-25' C.). In all rats at death, irrespective of the
inoculated subline, serum glucose was less than 10 mg. per 100 ml.
WBP1 (X) subline.-It was hoped that studies with this subline, more malig-
nant than WBPl (V), might accentuate any differences betweenprimary tumour-
induced affects and non-specific changes occurring in dying animals. Rats were
injected with X cells (I x 107i.p.) and pooled sera obtained at intervals for a
restricted series ofbiochemicalanalyses; inaddition,spleens,thymuses, mesenteric
lymph nodes and solid abdominal tumours were weighed and erythrocyte PCV's
determined (cf. Williams el al., 1968). Although X killed quicker, the amount of
tumourpresent (Table 1) and its effect on the PCV (41%) was smaller than that of
V (23%) at death (normal PCV: 50%). Serum glucose concentrations at death
(II mg. per I00ml.) were comparable with the terminal values associated with V
and A sublines. Veryhigh SGOT values (> 2000 units perml.) were observed but
changes in other serum components were smallerthanthose associated withtheless
malignant sublines (Table 11).HYPOGLYCAEMIA AND MALIGNANCY DIFFERENCES 99
TABLEI.-Organ Weights as a Measure of Visceral Invasion by Sublines
WBPI (X) and WBPI (V)
g. organ _x 100
g. body weight
A
Tumour inoculatedt rats at death
A
Organ Normal rats* WBPI (X) WBPI (V)*
Spleen 0-18±0-03t 0-60±0-08 0-61±0- 08
Thymus. 0-08±0- 04 0-37±0- 10 0- 87±0-36
Solid abdominal tumour 1-694-0-44 3-54±0-53
Mesenteric lymph node 0.19±0.10 0.15±0.10 0-41±0- 20
* Data from Williams el al., 1968.
t Rats received WBPI (X) or WBPI (V) cells (1 x 101) intraperitoneally. Fiducial limits (96%).
TABLE II.-Changes in Serum Components during Growth of WBPI (X) Subline
Mean value Time (days) post-inoculation*
normal rats A At
Serum component (units) ±95% limits 2 4 6 8 10 II death
Glucose (mg./100 ml.) 217-1±16-9 188t 188 210 191 130 23 11
SGOT (K units/ml.) 145- 7±20-1 246 175 250 450 720 1200 2040
Potassium (mEq./l.) 6-5±0-5 6- 3 7-1 5- 7 6-3 6-8 8- 2
Iron (/tg./100 ml.) 192±24 173 193 185 185 185 173
Alkaline phosphatase
(units/100 ml.) 27-0±1-9 28 26 26 26 22 22
Urea (mg./100 ml.) 43-1±2-1 42 39 44 37 35 40
Albumin (g./100 ml.) 3-2±0-12 3- 2 3-0 3-0 3
- 0 3-0 2
- 8
Globulin (g./100 ml.) 3-6±0-15 3- 8 4- 0 3
- 8 3
- 8 3- 9 3- 6
* Rats received WBPI (X) cells (1 x 107) intraperitoneally.
t Each value was obtained from a pool of sera from 4 rats.
Serum glucose concentration8in insulin-induced hypoglycaemic death
To demonstrate that the low glucose concentration in the sera of rats dying from WBPI tumour could belethal, hypoglyeaemia was induced in normal ratsby injection ofinsulin. The mean serumglucose concentration of seven rats, starved
for 48 hours was 180-6 --FI "m-f-r-Y (s.e.) mg. per 100 ml. Insulin (0-2-0-4 unit) was
injected subcutaneously at hourly intervals. Serum glucose concentrations and
rectal temperatures were monitored and the general condition of the animals
observed. After 4 hours, the mean glucose concentration was 54-6 ± 7-3 mg. per 100 ml. serum. The mean rectal temperature was 33-4 ± 0.40 C. and the rats
were lethargic with ruffled fur. Further insulin injections caused a continued
decrease in serum glucose concentrations and rectal temperatures. All the rats
died between 6 and 11 hours after the first insulin injection with serum glucose concentrations <II mg. per 100 ml. and rectaltemperatures of25-28' C. (ambient 200 C.).
The effect ofinjections ofglucose on the survival of rats bearing WBPI (X) subline
Attempts were made to prolong the life ofrats carrying X subline byinjecting glucose solutionsintraperitoneally. Technical difficulties were encountered which
could not be completely overcome. Hypertonic solutions ofglucose were toxic.
Hence to provide sufficient glucose, large volumes (Up tO 5 ml. ofisotonic glucose solution (5-5%) at 1-4 hour intervals for 5-8 days) had to beinjected, with conse-100 KILLINGTON, WILLIAMS, RATCLIFFE, WHITEHEAD AND SMITH
quent strain on the fluid balance mechanisms ofthe animals. Itproved difficult to
maintain the serum glucose concentration in the normal range and in some cases
over-administration of glucose produced a fatal hyperglycaemia (> 600 mg./
100 ml. serum). Two methods of infusion were tried. (1) Rats were lightly
anaesthetized andrepeatedlyinjectedintraperitoneallywith asyringe; over several
days they showed signs of shock and subcutaneous haemorrhage. (2) The
peritoneal cavities ofrats were cannulated (seemethods) 9days afterinoculation of
X cells and isotonic glucose solution injectedthrough the cannula either continu-
ously by peristaltic pump or manually at intervals. This avoided the repetitive
trauma of method (1) and improved the condition ofthe rats. Control groups of
tumour-bearing rats were infused with saline instead of glucose solution. The
serumglucose concentration Was monitored as aguide totheinjection rates andthe
serum glucose concentrations at death were determined. Using method (2) a
significant (P < 0-001)prolongation oflife was achieved in WBPI (X)-bearing rats
injected with glucose compared with control animals (Table 111). The final
glucoseinjection wasgiven at 13-75days to the 2 surviving rats. Following with-
drawal of treatment they rapidly became hypoglyeaemic and died 6 and 9 hours
laterrespectively.
TABLEIII.-Prolongation ofSurvivalof WBP1 (X)-bearing Rats by Iniection8
of Glucose
Times (days) of death of individual rats post-inoculation*
Controlst
A
Cannula inserted; Experimentalt Saline infused rats restrained; Glucose infused
i.p. by cannula no liquid infused Unoperated rats i.p. by cannula
10-19 10-25 10-98 11-92
10-27 11-08 11-21 13-04
10-56 11-58 11-54 14-00
11-50 14-08
Means 10-63 10-97 11-24
Overall meanst
=10
- 92±0
- 18 13-26±0-51
All rats received WBP1 (X) cells (1 x 107) intraperitoneally.
t Means ± standard error; the means of the glucose treated and control rats differ significantly (P < 0
-001).
Serum glucose levels in all rats at death were < 10mg./100 ml.
Inva8ionof organs controlling glucose homeo8tasis
In addition to growing as ascites tumours, the WBP1 sublines metastasized
widely and might have caused hypoglyeaemia by physical destruction of organs controlling glucose metabolism. Histological examination of pancreas and
adrenal glands from rats injected intraperitoneally with A, V or X cells (I x 107)
showed progressive infiltration by tumour cells. However, the disruption of
normal tissue was no greater after 15-17 days in the ratsdying ofV subline than in
those carrying A subline although the latter group would survive for another 2-3
weeks.
Terminal serum glucose levels after8ubcutaneous injection of tumour
If tumour cells of any of the sublines were injected subcutaneously, a large local solid tumour developed and adjacent lymph nodes were heavily invaded;101 HYPOGLYCAEMIA AND MALIGNANCY DIFFERENCES
however, minimal infiltration of the viscera, the pancreas and adrenal glands
occurred. Nevertheless, at death, glucose concentrations of < 10 mg. per 100 ml.
serum were measured, accompanied by rectal temperatures of 26-32' C.
DISCUSSION
Studies on the biochemical basis ofpathological change are besetby difficulties
ofdistinguishing cause fromeffect andspecificchangesfromsecondary-effectsofthe
disease processes. Manychanges in serum components observedduringgrowth of
the WBPI tumours, particularly those occurring during the later stages of the
disease, were undoubtedly due to the secondary e.ffects. The serum changes
observedduringgrowth ofthehighlymalignantWBPI (X)supportthishypothesis.
Apart from the decreased glucose and high SGOT values, the changes were less
severe than in the more prolonged disease produced by WBPI (V) and WBPI (A)
and the terminal values observed in all the rats were unlikely to cause death.
Glucose and SGOT changes appeared the most significant. They were detect-
able early in tumour growth and their onset and severity correlated with the
malignancy of the subline. SGOT concentrations are high in diseases producing
tissue destruction, particularly ofthe heart orliver, but as far as we are aware are
never fatal. Total tissue damage by invading tumour cells is greatest in rats
carrying WBP1 (A) and therefore the higher SGOT values'associated withgrowth ofV and X sublines may indicate additional damagebycytotoxic factorspossibly
producedby the tumour cells. It is of course alwayspossible that the SGOT may
be produced by the tumour cells.
Glucose wastheonly serumcomponent measuredthat showedthe same concen-
tration at death in rats dying from any of the sublines. This concentration
(approximately 10 mg. per 100 ml. serum) and the associated severe hypothermia
also occurred in ratsdying ofinsulin-inducedhypoglyeaemia and inpatientsdying with hypoglyeaemic shock (Marble, 1952; Williams, 1962; Himwich, 1951; Kedes
andField, 1964). Although it was notpossible toprolong lifeindefinitely, signifi-
cant survival was achievedbyglucose infusion. Thehypoglyeaemia causedbythe
sublines was far more severe than those recorded previously in experimental
tumour systems (Victor and Potter, 1938; Silverstein, Wakim, Bahn and Bayrd,
1960).
Thus, hypoglycaemia is the probable cause of death from the WBPI sublines
and the ability of a subline to induce this condition is one important factor deter-
mining its degree ofmalignancy. The early appearance ofhypoglycaemia during tumour growth when the amount of tumour was small and metastasis limited
suggested that the effect was specifically induced by the tumour and not a secon-
dary change.
Cases ofdeathbyhypoglycaemic shock due toextra-pancreaticneoplasms have
been reported in man (Lowbeer, 1961; O'Neill and Mikuta, 1970) and several
explanations have been suggested (Lowbeer, 1961; Marks and Rose, 1965; Unger, 1966; Silverstein, 1969). Firstly, invasion and destruction of organs controlling glucose metabolism; this seemed an unlikely explanation for the WBP1-induced
hypoglycaemia, as the latter appeared to be unrelated to the extent ofpancreatic and adrenal invasion and to the distribution of metastases. Secondly, hypo- glyeaemia may result from over-utilization ofglucose by the tumour; this effect
may have beensignificant in the terminalstages ofWBPl growth but isunlikely to102 KILLINGTON, WILLIAMS. RATCLIFFE. WHITEHEAD AND SMITH
be thecompleteexplanation ashypoglycaemia was detected after 8days for WBPI
(V) and WBPI (X), when the tumour was only about 1-2% of the total body
weight (cf. Williams d al., 1968). Thirdly, hypoglycaemia might result from the
disruption ofglucose homeostasisby a substanceproducedby the tumour orby its
interaction with normal tissues. Such a substance, for example, might stimulate
the action of normal control mechanisms, such as the production of insulin, or
function in an insulin-like manner or inhibit the production ofglucose by glyco-
genolysis or gluconeogenesis. The sensitivity to hyperglycaemia induced by
glucose administration, offormerly hypoglyeaemic rats dying of WBPI tumour,
indicates disturbance ofglucose metabolism. The marked correlation between the
rates of decrease of serum glucose and increase of SGOT suggests a relationship
between the effects. The tumour may damage cells concerned with glucose
homeostasis causing hypoglycaemia and the release of intracellular transaminase.
Identification ofthe source ofthe enzyme may thus lead to anexplanation for the
hypoglyeaemia.
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ADDENDUM
STUDIES ON A POSSIBLE MICROBIAL AETIOLOGY FOR THE DIFFERENCES IN
MALIGNANCY BETWEEN THE WBPI SUBLINES
A. E. WILLIAMS AND N. A. RATCLIFFE
From the Department ofMicrobiology, The University, Birmingham 15
THE malignancies ofthe sublines ofthe WBP1 rat tumour are related to their
abilities to induce a fatal hypoglycaemia (see above). The more malignant sub-
lines, V and X, arose during serial ascites passage ofthe A subline, presumablyby
selection of more malignant cells from the total population. However, the appa-
rent increase in malignancy could have been due to the acquisition of an infectious
agent, during animal passage, which contributed to thepathological effects, either
independently or in conjunction with the tumour cells. The association of such
agents with transplantable tumours and their contribution to the overall disease
syndrome have been reported (Belcher and Simpson, 1960; Davies, Cross and
Lapis, 1962; Stansly, 1965). It appeared unlikely that such an association had
occurred in the WBPI system as the tumours had been passaged for a relatively
shortperiod and thepathogenesis ofthethree sublines wassimilar, although occur-
ring at different rates. Nevertheless, evidence to support this view was desirable,
because the relevance of the studies on hypoglyeaemia to the biology of cancer
depended on there being a genuine difference in malignancy between the sublines.
Such evidence wouldnecessarily benegative, i.e. the absence of an infectious agent would be indicated by the failure ofexperiments designed to detect its presence.
Despite this limitation, four investigations to demonstrate the pre.sence of a
pathogenic butnon-oncogenic agent in the V tumour were undertakenby methods
that have beensuccessfullyusedpreviously(Stansly, 1965). No evidence that any infectious agent was responsible for the differences in malignancy was obtained.
First, normal rats and mice were examined forpathological effectsfollowing the
injection of extracts of V cells or of serum from rats bearing the V tumour (cf.
Davies etal., 1962), so that anychanges could be compared with thoseproducedby activetumourgrowth(Williamsetal.,1968;Killingtonetal.,1971). Vcellsuspen- sions, disruptedbyultrasonication, homogenization (two methods) orfreezing and
thawing, werecentrifuged (26,000 x g 30 min., 4' C.) and thesupernatants filtered
(0-22 #pore membrane filter). These extracts were termed V15. Some V15
extracts were further centrifuged (150,000 x g, 90 min., 4' C.); the supernatant (V45s) and thepelletsresuspended inTyrode solution (V45p) were then filtered (as